Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-05-19

FDA Approved: MORPHINE SULFATE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)

View source ↗

Summary

FDA approved a supplemental application for Morphine Sulfate by Amneal Pharmaceuticals of New York LLC under ANDA 200411, granting a supplemental approval for t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MORPHINE SULFATE (MORPHINE SULFATE)

Snippet

SUPPL AP for MORPHINE SULFATE (MORPHINE SULFATE)